PMID- 10748205 OWN - NLM STAT- MEDLINE DCOM- 20000630 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 275 IP - 21 DP - 2000 May 26 TI - The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. PG - 16373-81 AB - C/EBPalpha, beta, and delta are all expressed by bone marrow-derived macrophages. Ectopic expression of any of these transcription factors is sufficient to confer lipopolysaccharide (LPS)-inducible expression of interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) to a B lymphoblast cell line, which normally lacks C/EBP factors and does not display LPS induction of proinflammatory cytokines. Thus, the activities of C/EBPalpha, beta, and delta are redundant in regard to expression of IL-6 and MCP-1. Surprisingly, the bZIP region of C/EBPbeta, which lacks any previously described activation domains, can also confer LPS-inducible expression of IL-6 and MCP-1 in stable transfectants. Transient transfections reveal that the bZIP regions of C/EBPbeta, C/EBPdelta, and, to a lesser extent, C/EBPalpha can activate the IL-6 promoter and augment its induction by LPS. Furthermore, the transdominant inhibitor, LIP, can activate expression from the IL-6 promoter. The ability of the C/EBPbeta bZIP region to activate the IL-6 promoter in transient transfections is completely dependent upon an intact NF-kappaB-binding site, supporting a model where the bZIP protein primarily functions to augment the activity of NF-kappaB. Replacement of the leucine zipper of C/EBPbeta with that of GCN4 yields a chimeric protein that can dimerize and specifically bind to a C/EBP consensus sequence, but shows a markedly reduced ability to activate IL-6 and MCP-1 expression. These results implicate the leucine zipper domain in some function other than dimerization with known C/EBP family members, and suggest that C/EBP redundancy in regulating cytokine expression may result from their highly related bZIP regions. FAU - Hu, H M AU - Hu HM AD - Department of Microbiology, Michigan State University, East Lansing, Michigan 48824-1101, USA. FAU - Tian, Q AU - Tian Q FAU - Baer, M AU - Baer M FAU - Spooner, C J AU - Spooner CJ FAU - Williams, S C AU - Williams SC FAU - Johnson, P F AU - Johnson PF FAU - Schwartz, R C AU - Schwartz RC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (CCAAT-Enhancer-Binding Protein-beta) RN - 0 (CCAAT-Enhancer-Binding Proteins) RN - 0 (Chemokine CCL2) RN - 0 (DNA-Binding Proteins) RN - 0 (Fungal Proteins) RN - 0 (Interleukin-6) RN - 0 (Lipopolysaccharides) RN - 0 (NF-kappa B) RN - 0 (Nuclear Proteins) RN - 0 (Protein Isoforms) RN - 0 (Recombinant Fusion Proteins) RN - 0 (Repressor Proteins) RN - 0 (Saccharomyces cerevisiae Proteins) RN - 0 (Transcription Factors) RN - EC 2.7.- (Protein Kinases) SB - IM MH - Animals MH - B-Lymphocytes MH - Binding Sites MH - CCAAT-Enhancer-Binding Protein-beta MH - CCAAT-Enhancer-Binding Proteins MH - Cell Line MH - Chemokine CCL2/*biosynthesis/genetics MH - DNA-Binding Proteins/genetics/*metabolism MH - Dimerization MH - Fungal Proteins/genetics MH - Gene Expression Regulation MH - Interleukin-6/*biosynthesis/genetics MH - Leucine Zippers/*genetics MH - Lipopolysaccharides/*pharmacology MH - Mice MH - NF-kappa B/metabolism MH - Nuclear Proteins/analysis/genetics/*metabolism MH - Promoter Regions, Genetic MH - Protein Isoforms/metabolism MH - Protein Kinases/genetics MH - Recombinant Fusion Proteins/genetics MH - Repressor Proteins/pharmacology MH - *Saccharomyces cerevisiae Proteins MH - Transcription Factors/genetics/*metabolism MH - Transcriptional Activation MH - Transfection EDAT- 2000/04/05 09:00 MHDA- 2000/07/08 11:00 CRDT- 2000/04/05 09:00 PHST- 2000/04/05 09:00 [pubmed] PHST- 2000/07/08 11:00 [medline] PHST- 2000/04/05 09:00 [entrez] AID - S0021-9258(19)80439-8 [pii] AID - 10.1074/jbc.M910269199 [doi] PST - ppublish SO - J Biol Chem. 2000 May 26;275(21):16373-81. doi: 10.1074/jbc.M910269199.